National Access Director - West
This is the employer's own posting, not a copy on a job board.
What we know
Is it still open?
Confirmed still open
Last checked 3d ago — checked against the employer's own applicant tracking system, which is the company answering directly.
We re-read the employer's own applicant tracking system and the posting was still there. That is the company answering directly.
How old is it?
Posted 3d ago
The date the source published, not the day we noticed it (2026-10-30). Last seen at its source 4h ago.
We have tracked this listing since 30 Oct 2026 (3 days). The employer's own board has carried it every time we have read it, most recently 4 hours ago.
Is it remote?
USA - Remote 100%
That is the location the employer filed this posting under. Quoted as written — we do not re-word the source's own location.
Who may apply?
United States
The description agrees: it names United States.
What the ad says
…LOCATION: US, remote, domestic travel up to 30% Compensation and Benef…
Pay
$200k–270k/yr
Read out of the job description by us, not from a structured field. Shown in the posting's own currency and period; we never convert.
Skills named in the ad
Recognised terms only, from a fixed vocabulary — this is what CV matching compares against.
Carried by 1 source
-
Workday employer's own board first seen 3d ago · last seen 4h ago
The listing
We are looking for creative, highly motivated individuals to help prepare for the successful launch of an innovative allogeneic T-cell immunotherapy in the US, Tabelecleucel (Tab-Cel) which is an investigational cell therapy for the treatment of Epstein Barr positive post-transplant lymphoproliferative disease.
The U.S. Food and Drug Administration (FDA) accepted the Biologics License Application (BLA) resubmission for tabelecleucel (tab-cel® / Ebvallo), setting a target action date of March 31, 2027, under the Prescription Drug User Fee Act (PDUFA).
The National Access Director will play a critical role in preparing for launch and facilitating urgent access to Tab-cel once approved. In the pre-approval phase, they will work closely with Pierre Fabre’s Cell Therapy Account Directors and Field Medical Directors to support site operational onboarding and readiness leading up to and after the anticipated approval of the Tab-Cel. They will be responsible for pre- and post-approval information exchanges with payers to ensure payers have the appropriate data and information required to enable coverage decisions and provide a pathway to coverage for patients who may be prescribed the Tab-cel post approval. Critically, they will ensure that financial stakeholders at treating facilities and payers have timely access to information needed to navigate the preparation for the relevant prior authorization process and potential single case agreements.
This is an exciting opportunity to be part of an organization that is preparing to launch a new class of advanced therapeutics while making a meaningful impact on the lives of patients with a life-threatening disease. Pierre Fabre Pharmaceuticals offers unique development opportunities, and we are looking for candidates that have a growth mindset and thrive in a start-up environment that will be scaling up the Pierre Fabre presence in the US pharmaceuticals market. We value individuals who exhibit behaviors such as team collaboration, humility, innovative thinking, and patient centric approach to the business.
ESSENTIAL FUNCTIONS:
- Operate in compliance with all laws, regulations and policies that govern the conduct of Pierre Fabre activities
- Facilitate urgent access to Tab-cel post approval by educating payer customer segment and treatment center financial stakeholders of value proposition of product
- Contributes to the US Value and Access Team by monitoring trends, policy changes, and implications and taking ownership of this expertise
- Seek opportunities for synergy and partnership to achieve both Pierre Fabre and customer goals through active and transparent planning and customer engagement with cross functional Team
Tab-Cel Support
- Enable payer coverage assessment for Tab-Cel through pre-approval information exchange and post-approval with national and regional payers in the Commercial, Medicare, and VA sectors
- Support overall access strategy with engagement of Federal Payers and Medicare FFS
- Educate payers on the urgent unmet need and provide resources to ensure a pathway to coverage in the pre and post approval regulatory setting
- Identify appropriate payer stakeholders for the therapy and partner with payer colleagues to establish path for expedited review of cases
- Provide approved product education and health economic information to key customers in payer and provider segment to communicate the value proposition of the product.
- Ensure financial and reimbursement confidence and communicate payer coverage with providers post approval
- Partner with treatment sites and key stakeholders to educate on reimbursement process, coverage and coding details relevant for the Therapy post approval, ensuring stakeholder comfort and confidence in their reimbursement process
- Liaise with external specialty distributor counterpart(s) to meet objectives while providing a best-in-class experience for sites of care
- Proactively communicate payer coverage criteria to internal field teams and external site of care stakeholders
- Prepare potential treatment centers to be reimbursement ready before and after anticipated approval
- Ensure that providers and payers have timely access to information needed to navigate prior authorizations and the negotiation of single-case agreements (e.g. coding, relevant policy, setting of care considerations)
- The National Access Director will be the primary field team member responsible for education regarding patient assistance programs at sites of care
- The National Access Director is the field expert in market access related issues related to Trade Policy National Access Director is responsible for partnering with payer relations teams at sites of care to resolve any issues regarding coverage and reimbursement
Other duties and responsibilities may be assigned as required based on evolving business needs.
REQUIRED EDUCATION AND EXPERIENCE
- Bachelor’s degree required, healthcare degrees or credentials desirable
- Strong, pre-existing working experience with national and regional payers that manage medical and pharmacy benefit policy
- Deep knowledge of and experience with inpatient and outpatient reimbursement methodology and dynamics and impacts to hospital access economics
- 10+ years of biotech/pharma required with at least two years of direct experience in coverage and reimbursement dynamics of complex advanced therapies (E.g. cell therapy, gene therapy, radio ligand
Strongly Preferred
- Experience with cell and gene therapy networks and Medical Director teams at payers that manage Cell Therapy products
- Strong presentation skills and executive presence
- Exceptional business acumen and hospital administrative expertise
- Cell, Gene, Stem Cell Transplant service line experience and established relationships with financial KOLs at institutions
- Ability to work in fast-paced and dynamic environment while maintaining cross functional internal relationships and contribute to site of care account planning
- Experience with pharmacy/ therapeutics committee and high impact drug review processes at institutions
LOCATION:
US, remote, domestic travel up to 30%
Compensation and Benefits:
Anticipated Salary Range: $200,000 -$270,000
This range represents the base annual full-time salary for all positions within the applicable job grade. The actual salary offer will depend on a range of factors including experience, education, location, and other relevant qualifications. This position is also eligible for a Pierre Fabre bonus, commission, or incentive program in addition to the base pay.
Employees will be eligible to participate in a comprehensive benefits package that includes medical, dental, and vision coverage, voluntary benefits, a 401(k) retirement plan, a generous PTO policy, paid company holidays, and paid parental leave. Additional offerings include employee discounts on our products, professional development opportunities, and access to mental health and wellness programs.
Pierre Fabre
https://www.pierrefabrepharmaceuticals.com/
We are convinced that diversity is a source of fulfillment, social balance and complementarity for our employees, which is why our offers are open to all, without restriction.